2022年6期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預防、臨床治療研究方面的新進展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學，實驗腫瘤學、腫瘤細胞分子生物學，腫瘤病理學以及腫瘤影像診斷、腫瘤外科治療、化學治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學科，旨在促進國內(nèi)外學術(shù)交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
Review Article
Perspective
- Postoperative functional evaluation of gastrectomy for gastric cancer
- Advances in gastric cancer research will light the way to control this cancer
- Evolution of laparoscopic gastrectomy for cancer in the East and West
- Advances in surgical techniques for gastric cancer: Indocyanine green and near-infrared fluorescence imaging.Is it ready for prime time?
Original Article
- Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic,multicenter,and prospective clinical trial in China
- A multi-center,open-label,randomized,parallel-controlled phase II study comparing pharmacokinetic,pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera?) in patients with CD20-positive B-cell non-Hodgkin lymphoma
- Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1expression in remnant gastric cancer
Clinical Practice
Editorial
- Comments on National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
- Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)